BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34358384)

  • 1. Clinical experience with non-invasive prenatal screening for single-gene disorders.
    Mohan P; Lemoine J; Trotter C; Rakova I; Billings P; Peacock S; Kao CY; Wang Y; Xia F; Eng CM; Benn P
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):33-39. PubMed ID: 34358384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive cell-free DNA prenatal screening for trisomy 21 as part of primary screening strategy in twin pregnancy.
    Claudel N; Barrois M; Vivanti AJ; Rosenblatt J; Salomon LJ; Jouannic JM; Picone O; Carbillon L; Vialard F; Launay E; Tsatsaris V; Curis E; El Khattabi L;
    Ultrasound Obstet Gynecol; 2024 Jun; 63(6):807-814. PubMed ID: 37470702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.
    Bevilacqua E; Jani JC; Chaoui R; Suk EA; Palma-Dias R; Ko TM; Warsof S; Stokowski R; Jones KJ; Grati FR; Schmid M
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):597-602. PubMed ID: 34090308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA.
    Zhang J; Li J; Saucier JB; Feng Y; Jiang Y; Sinson J; McCombs AK; Schmitt ES; Peacock S; Chen S; Dai H; Ge X; Wang G; Shaw CA; Mei H; Breman A; Xia F; Yang Y; Purgason A; Pourpak A; Chen Z; Wang X; Wang Y; Kulkarni S; Choy KW; Wapner RJ; Van den Veyver IB; Beaudet A; Parmar S; Wong LJ; Eng CM
    Nat Med; 2019 Mar; 25(3):439-447. PubMed ID: 30692697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
    Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
    Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
    BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
    Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience across the fetal-fraction spectrum of a non-invasive prenatal screening approach with low test-failure rate.
    Hancock S; Ben-Shachar R; Adusei C; Oyolu CB; Evans EA; Kang HP; Haverty C; Muzzey D
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):422-430. PubMed ID: 31671482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of amplicon-based sequencing for testing fetal identity and monogenic traits with Single Circulating Trophoblast (SCT) as one form of cell-based NIPT.
    Zhuo X; Wang Q; Vossaert L; Salman R; Kim A; Van den Veyver I; Breman A; Beaudet A
    PLoS One; 2021; 16(4):e0249695. PubMed ID: 33857205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive prenatal testing: from aneuploidy to single genes.
    Guseh SH
    Hum Genet; 2020 Sep; 139(9):1141-1148. PubMed ID: 31555907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Extensive Next-Generation Sequencing Method for Monogenic Disorder Analysis on Cell-Free Fetal DNA: Noninvasive Prenatal Diagnosis.
    Dello Russo C; Cesta A; Longo S; Barone MA; Cima A; Mesoraca A; Sparacino D; Viola A; Giorlandino C
    J Mol Diagn; 2019 Jul; 21(4):572-579. PubMed ID: 31028936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing and validating noninvasive prenatal testing for
    Nguyen NY; Lu YT; Nguyen DA; Nguyen CC; Dinh LT; Tran MT; Tran DC; Luong LT; Doan KP; Huy Nguyen VQ; Thi Ha TM; Truong LT; Tran NT; Cao PT; Tran VT; Nhut Trinh TH; Le QT; Nguyen VT; Hoang DT; Vo ST; Nguyen MB; Bui CT; Tran ST; Lam DT; Le HT; Nguyen MB; Ho VT; Nguyen MT; Doan PL; Tran KT; Tran HT; Tran UV; Dinh AM; Nguyen TT; Do TT; Truong DK; Phan MD; Nguyen HN; Tang HS; Giang H
    Per Med; 2023 Sep; 20(5):425-433. PubMed ID: 37623819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.